Merck & Co., Inc. (MRK) Stock Price

MRKStock
$156.45+72.44%52W
Market Cap$385.99B
P/E18.05x
PEG Ratio14.56
Div yield2.87%
Beta0.21

MRK Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)12.59%
Price vs S&P 500 (4W)11.24%
PEG Ratio14.56
VGM Score58.23
P/E Ratio (Annual)18.05x
Indicated Dividend Yield (Annual)2.87%

MRK Earnings Surprise History

Q2 252.13est. 2.03
Q3 252.58est. 2.35
Q4 252.04est. 2.01
Q1 26-1.28est. -1.47
Q2 26-0.13est. -0.26

MRK Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.94
3.94
3.94
3.94

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
MRKMerck & Co., Inc.
DCA$156.45
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85
BMYBristol-Myers Squibb Co.BBB$67.92

About Merck & Co., Inc.

Merck is a diversified pharmaceutical company with a leading immuno-oncology franchise anchored by Keytruda, a substantial vaccine business including Gardasil, and cardiometabolic disease treatments. The company also operates animal health segments globally, with 47% of revenue derived from US human pharmaceuticals and vaccines.